LLY logo

Eli Lilly and Company (LLY) Revenue

Annual revenue:

$45.04B+$10.92B(+32.00%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY annual revenue is $45.04 billion, with the most recent change of +$10.92 billion (+32.00%) on December 31, 2024.
  • During the last 3 years, LLY annual revenue has risen by +$16.72 billion (+59.06%).
  • LLY annual revenue is now at all-time high.

Performance

LLY Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

Quarterly revenue:

$13.53B+$2.09B(+18.30%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY quarterly revenue is $13.53 billion, with the most recent change of +$2.09 billion (+18.30%) on December 31, 2024.
  • Over the past year, LLY quarterly revenue has stayed the same.
  • LLY quarterly revenue is now at all-time high.

Performance

LLY Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

TTM revenue:

$45.04B+$4.18B(+10.23%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY TTM revenue is $45.04 billion, with the most recent change of +$4.18 billion (+10.23%) on December 31, 2024.
  • Over the past year, LLY TTM revenue has stayed the same.
  • LLY TTM revenue is now at all-time high.

Performance

LLY TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

LLY Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+32.0%0.0%0.0%
3 y3 years+59.1%+94.4%+62.7%
5 y5 years+101.8%+94.4%+62.7%

LLY Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+59.1%at high+108.6%at high+62.7%
5 y5-yearat high+101.8%at high+146.1%at high+96.3%
alltimeall timeat high+1348.7%at high+2238.5%at high+4933.8%

Eli Lilly and Company Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$45.04B(+32.0%)
$13.53B(+18.3%)
$45.04B(+10.2%)
Sep 2024
-
$11.44B(+1.2%)
$40.86B(+5.0%)
Jun 2024
-
$11.30B(+28.9%)
$38.92B(+8.3%)
Mar 2024
-
$8.77B(-6.3%)
$35.93B(+5.3%)
Dec 2023
$34.12B(+19.6%)
$9.35B(-1.5%)
$34.12B(+6.4%)
Sep 2023
-
$9.50B(+14.3%)
$32.07B(+8.7%)
Jun 2023
-
$8.31B(+19.4%)
$29.52B(+6.6%)
Mar 2023
-
$6.96B(-4.7%)
$27.69B(-3.0%)
Dec 2022
$28.54B(+0.8%)
$7.30B(+5.2%)
$28.54B(-2.4%)
Sep 2022
-
$6.94B(+7.0%)
$29.24B(+0.6%)
Jun 2022
-
$6.49B(-16.9%)
$29.07B(-0.9%)
Mar 2022
-
$7.81B(-2.4%)
$29.32B(+3.5%)
Dec 2021
$28.32B(+15.4%)
$8.00B(+18.1%)
$28.32B(+2.0%)
Sep 2021
-
$6.77B(+0.5%)
$27.76B(+3.9%)
Jun 2021
-
$6.74B(-1.0%)
$26.73B(+4.9%)
Mar 2021
-
$6.81B(-8.5%)
$25.49B(+3.9%)
Dec 2020
$24.54B(+9.9%)
$7.44B(+29.6%)
$24.54B(+5.7%)
Sep 2020
-
$5.74B(+4.4%)
$23.21B(+1.2%)
Jun 2020
-
$5.50B(-6.2%)
$22.95B(-0.6%)
Mar 2020
-
$5.86B(-4.2%)
$23.09B(+3.4%)
Dec 2019
$22.32B(+3.8%)
$6.11B(+11.6%)
$22.32B(+2.2%)
Sep 2019
-
$5.48B(-2.8%)
$21.84B(+0.8%)
Jun 2019
-
$5.64B(+10.7%)
$21.67B(+0.2%)
Mar 2019
-
$5.09B(-9.7%)
$21.62B(+0.6%)
Dec 2018
$21.49B(+7.6%)
$5.64B(+6.2%)
$21.49B(+12.4%)
Sep 2018
-
$5.31B(-5.0%)
$19.12B(-1.8%)
Jun 2018
-
$5.58B(+12.5%)
$19.47B(-1.2%)
Mar 2018
-
$4.96B(+52.1%)
$19.71B(-1.3%)
Dec 2017
$19.97B(-5.9%)
$3.26B(-42.3%)
$19.97B(-11.1%)
Sep 2017
-
$5.66B(-2.9%)
$22.47B(+2.1%)
Jun 2017
-
$5.82B(+11.4%)
$22.00B(+1.9%)
Mar 2017
-
$5.23B(-9.2%)
$21.59B(+1.7%)
Dec 2016
$21.22B(+6.3%)
$5.76B(+11.0%)
$21.22B(+1.8%)
Sep 2016
-
$5.19B(-3.9%)
$20.84B(+1.1%)
Jun 2016
-
$5.40B(+11.1%)
$20.61B(+2.1%)
Mar 2016
-
$4.87B(-9.5%)
$20.18B(+1.1%)
Dec 2015
$19.96B(+1.7%)
$5.38B(+8.4%)
$19.96B(+1.3%)
Sep 2015
-
$4.96B(-0.4%)
$19.70B(+0.4%)
Jun 2015
-
$4.98B(+7.2%)
$19.62B(+0.2%)
Mar 2015
-
$4.64B(-9.3%)
$19.58B(-0.2%)
Dec 2014
$19.62B(-15.1%)
$5.12B(+5.0%)
$19.62B(-3.4%)
Sep 2014
-
$4.88B(-1.2%)
$20.30B(-4.2%)
Jun 2014
-
$4.94B(+5.4%)
$21.20B(-4.5%)
Mar 2014
-
$4.68B(-19.4%)
$22.19B(-4.0%)
Dec 2013
$23.11B(+2.3%)
$5.81B(+0.6%)
$23.11B(-0.6%)
Sep 2013
-
$5.77B(-2.6%)
$23.26B(+1.4%)
Jun 2013
-
$5.93B(+5.8%)
$22.93B(+1.5%)
Mar 2013
-
$5.60B(-6.0%)
$22.60B(0.0%)
Dec 2012
$22.60B(-6.9%)
$5.96B(+9.4%)
$22.60B(-0.4%)
Sep 2012
-
$5.44B(-2.8%)
$22.69B(-3.0%)
Jun 2012
-
$5.60B(-0.0%)
$23.40B(-2.7%)
Mar 2012
-
$5.60B(-7.4%)
$24.05B(-1.0%)
Dec 2011
$24.29B(+5.2%)
$6.05B(-1.6%)
$24.29B(-0.6%)
Sep 2011
-
$6.15B(-1.7%)
$24.43B(+2.1%)
Jun 2011
-
$6.25B(+7.1%)
$23.93B(+2.2%)
Mar 2011
-
$5.84B(-5.6%)
$23.43B(+1.5%)
Dec 2010
$23.08B(+5.7%)
$6.19B(+9.4%)
$23.08B(+1.1%)
Sep 2010
-
$5.65B(-1.6%)
$22.82B(+0.4%)
Jun 2010
-
$5.75B(+4.8%)
$22.73B(+2.0%)
Mar 2010
-
$5.49B(-7.6%)
$22.27B(+2.0%)
Dec 2009
$21.84B(+7.2%)
$5.93B(+6.7%)
$21.84B(+3.5%)
Sep 2009
-
$5.56B(+5.1%)
$21.11B(+1.7%)
Jun 2009
-
$5.29B(+4.9%)
$20.75B(+0.7%)
Mar 2009
-
$5.05B(-3.0%)
$20.61B(+1.2%)
Dec 2008
$20.37B(+9.3%)
$5.20B(-0.1%)
$20.37B(+0.1%)
Sep 2008
-
$5.21B(+1.1%)
$20.36B(+3.2%)
Jun 2008
-
$5.15B(+7.1%)
$19.73B(+2.7%)
Mar 2008
-
$4.81B(-7.4%)
$19.21B(+3.1%)
Dec 2007
$18.63B(+18.8%)
$5.19B(+13.1%)
$18.63B(+5.3%)
Sep 2007
-
$4.59B(-1.0%)
$17.69B(+4.3%)
Jun 2007
-
$4.63B(+9.6%)
$16.97B(+4.7%)
Mar 2007
-
$4.23B(-0.5%)
$16.20B(+3.3%)
Dec 2006
$15.69B(+7.1%)
$4.25B(+9.9%)
$15.69B(+2.4%)
Sep 2006
-
$3.86B(-0.1%)
$15.32B(+1.7%)
Jun 2006
-
$3.87B(+4.1%)
$15.06B(+1.3%)
Mar 2006
-
$3.71B(-4.2%)
$14.86B(+1.5%)
Dec 2005
$14.65B(+5.7%)
$3.88B(+7.7%)
$14.65B(+1.6%)
Sep 2005
-
$3.60B(-1.8%)
$14.41B(+2.3%)
Jun 2005
-
$3.67B(+4.9%)
$14.09B(+0.8%)
Mar 2005
-
$3.50B(-4.0%)
$13.98B(+0.9%)
Dec 2004
$13.86B
$3.64B(+11.1%)
$13.86B(+1.3%)
Sep 2004
-
$3.28B(-7.8%)
$13.68B(+1.0%)
DateAnnualQuarterlyTTM
Jun 2004
-
$3.56B(+5.3%)
$13.54B(+3.6%)
Mar 2004
-
$3.38B(-2.6%)
$13.07B(+3.9%)
Dec 2003
$12.58B(+13.6%)
$3.47B(+10.4%)
$12.58B(+4.2%)
Sep 2003
-
$3.14B(+1.7%)
$12.07B(+3.0%)
Jun 2003
-
$3.09B(+6.9%)
$11.72B(+2.7%)
Mar 2003
-
$2.89B(-2.2%)
$11.41B(+3.0%)
Dec 2002
$11.08B(-4.0%)
$2.96B(+6.1%)
$11.08B(+1.2%)
Sep 2002
-
$2.79B(+0.4%)
$10.95B(-0.8%)
Jun 2002
-
$2.78B(+8.4%)
$11.04B(-2.3%)
Mar 2002
-
$2.56B(-9.5%)
$11.30B(-2.1%)
Dec 2001
$11.54B(+6.3%)
$2.83B(-1.6%)
$11.54B(-1.3%)
Sep 2001
-
$2.87B(-5.2%)
$11.69B(+0.5%)
Jun 2001
-
$3.03B(+8.1%)
$11.63B(+3.7%)
Mar 2001
-
$2.81B(-5.8%)
$11.22B(+3.3%)
Dec 2000
$10.86B(+8.6%)
$2.98B(+5.9%)
$10.86B(+1.5%)
Sep 2000
-
$2.81B(+7.3%)
$10.71B(+2.2%)
Jun 2000
-
$2.62B(+7.0%)
$10.48B(+2.7%)
Mar 2000
-
$2.45B(-13.1%)
$10.20B(+2.0%)
Dec 1999
$10.00B(+8.3%)
$2.82B(+9.1%)
$10.00B(+1.9%)
Sep 1999
-
$2.59B(+10.4%)
$9.82B(+2.4%)
Jun 1999
-
$2.34B(+3.8%)
$9.59B(+2.0%)
Mar 1999
-
$2.26B(-14.4%)
$9.41B(+1.8%)
Dec 1998
$9.24B(+15.6%)
$2.64B(+11.7%)
$9.24B(+8.8%)
Sep 1998
-
$2.36B(+9.5%)
$8.49B(+2.4%)
Jun 1998
-
$2.15B(+3.3%)
$8.29B(+2.0%)
Mar 1998
-
$2.09B(+10.7%)
$8.12B(+1.7%)
Dec 1997
$7.99B(+14.1%)
$1.89B(-12.7%)
$7.99B(+2.2%)
Sep 1997
-
$2.16B(+8.6%)
$7.81B(+4.8%)
Jun 1997
-
$1.99B(+1.8%)
$7.46B(+4.1%)
Mar 1997
-
$1.95B(+14.0%)
$7.17B(+2.4%)
Dec 1996
$7.00B(+3.5%)
$1.71B(-5.1%)
$7.00B(-1.2%)
Sep 1996
-
$1.80B(+6.2%)
$7.09B(+2.5%)
Jun 1996
-
$1.70B(-4.8%)
$6.91B(+1.2%)
Mar 1996
-
$1.78B(-0.9%)
$6.83B(+1.0%)
Dec 1995
$6.76B(+18.4%)
$1.80B(+10.3%)
$6.76B(+22.0%)
Sep 1995
-
$1.63B(+1.1%)
$5.54B(-3.2%)
Jun 1995
-
$1.61B(-6.0%)
$5.73B(-1.1%)
Mar 1995
-
$1.72B(+196.8%)
$5.79B(+1.4%)
Dec 1994
$5.71B(-11.5%)
$578.70M(-68.2%)
$5.71B(-17.6%)
Sep 1994
-
$1.82B(+8.3%)
$6.93B(+4.3%)
Jun 1994
-
$1.68B(+2.5%)
$6.65B(+1.8%)
Mar 1994
-
$1.64B(-9.1%)
$6.53B(+1.2%)
Dec 1993
$6.45B(+4.6%)
$1.80B(+17.7%)
$6.45B(+2.3%)
Sep 1993
-
$1.53B(-1.9%)
$6.31B(+0.9%)
Jun 1993
-
$1.56B(+0.1%)
$6.25B(+1.3%)
Mar 1993
-
$1.56B(-5.8%)
$6.17B(+0.0%)
Dec 1992
$6.17B(+7.7%)
$1.66B(+12.1%)
$6.17B(+1.4%)
Sep 1992
-
$1.48B(-0.1%)
$6.08B(+2.3%)
Jun 1992
-
$1.48B(-5.1%)
$5.95B(+1.7%)
Mar 1992
-
$1.56B(-1.0%)
$5.85B(+2.1%)
Dec 1991
$5.73B(+10.3%)
$1.57B(+17.2%)
$5.73B(+2.3%)
Sep 1991
-
$1.34B(-2.5%)
$5.60B(+1.1%)
Jun 1991
-
$1.38B(-4.1%)
$5.54B(+2.8%)
Mar 1991
-
$1.44B(-0.6%)
$5.39B(+3.8%)
Dec 1990
$5.19B(+24.3%)
$1.44B(+12.6%)
$5.19B(+14.6%)
Sep 1990
-
$1.28B(+4.6%)
$4.53B(+5.5%)
Jun 1990
-
$1.23B(-1.2%)
$4.30B(+2.5%)
Mar 1990
-
$1.24B(+58.2%)
$4.19B(+0.4%)
Dec 1989
$4.18B(+2.6%)
$784.00M(-25.0%)
$4.18B(-5.8%)
Sep 1989
-
$1.05B(-6.8%)
$4.43B(+2.4%)
Jun 1989
-
$1.12B(-8.4%)
$4.33B(+2.5%)
Mar 1989
-
$1.23B(+17.5%)
$4.22B(+3.8%)
Dec 1988
$4.07B(+11.7%)
$1.04B(+10.8%)
$4.07B(+11.9%)
Sep 1988
-
$940.60M(-7.3%)
$3.64B(-0.5%)
Jun 1988
-
$1.01B(-5.4%)
$3.65B(-0.1%)
Mar 1988
-
$1.07B(+75.9%)
$3.66B(+0.4%)
Dec 1987
$3.64B(-2.1%)
$609.50M(-36.4%)
$3.64B(-9.0%)
Sep 1987
-
$957.70M(-5.9%)
$4.00B(+1.9%)
Jun 1987
-
$1.02B(-3.9%)
$3.93B(+3.6%)
Mar 1987
-
$1.06B(+9.2%)
$3.79B(+1.9%)
Dec 1986
$3.72B(+13.8%)
$969.40M(+9.7%)
$3.72B(+4.3%)
Sep 1986
-
$883.40M(+0.5%)
$3.57B(+2.8%)
Jun 1986
-
$879.30M(-11.0%)
$3.47B(+3.7%)
Mar 1986
-
$988.30M(+21.0%)
$3.35B(+2.4%)
Dec 1985
$3.27B(+5.2%)
$817.00M(+3.7%)
$3.27B(+1.2%)
Sep 1985
-
$787.90M(+4.1%)
$3.23B(+2.4%)
Jun 1985
-
$756.80M(-16.7%)
$3.16B(+1.1%)
Mar 1985
-
$908.80M(+16.8%)
$3.12B(+0.5%)
Dec 1984
$3.11B
$777.90M(+9.2%)
$3.11B(+33.4%)
Sep 1984
-
$712.60M(-1.6%)
$2.33B(+44.0%)
Jun 1984
-
$723.90M(-19.1%)
$1.62B(+80.9%)
Mar 1984
-
$894.80M
$894.80M

FAQ

  • What is Eli Lilly and Company annual revenue?
  • What is the all time high annual revenue for Eli Lilly and Company?
  • What is Eli Lilly and Company annual revenue year-on-year change?
  • What is Eli Lilly and Company quarterly revenue?
  • What is the all time high quarterly revenue for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly revenue year-on-year change?
  • What is Eli Lilly and Company TTM revenue?
  • What is the all time high TTM revenue for Eli Lilly and Company?
  • What is Eli Lilly and Company TTM revenue year-on-year change?

What is Eli Lilly and Company annual revenue?

The current annual revenue of LLY is $45.04B

What is the all time high annual revenue for Eli Lilly and Company?

Eli Lilly and Company all-time high annual revenue is $45.04B

What is Eli Lilly and Company annual revenue year-on-year change?

Over the past year, LLY annual revenue has changed by +$10.92B (+32.00%)

What is Eli Lilly and Company quarterly revenue?

The current quarterly revenue of LLY is $13.53B

What is the all time high quarterly revenue for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly revenue is $13.53B

What is Eli Lilly and Company quarterly revenue year-on-year change?

Over the past year, LLY quarterly revenue has changed by $0.00 (0.00%)

What is Eli Lilly and Company TTM revenue?

The current TTM revenue of LLY is $45.04B

What is the all time high TTM revenue for Eli Lilly and Company?

Eli Lilly and Company all-time high TTM revenue is $45.04B

What is Eli Lilly and Company TTM revenue year-on-year change?

Over the past year, LLY TTM revenue has changed by $0.00 (0.00%)
On this page